2Doherty DE, Henson PM, Clark RA. Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation[ J ]. J Clin Invest, 1990, 86 (4) : 1065-1075.
3He YF, Zhang GM, Wang XH, et al. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine[J]. J Immunol, 2004, 173(8) : 4919-4928.
4Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA[ J]. Gene Ther,1999, 6(7) : 1258-1266.
5Herweijer H, Wolff JA. Progress and prospects : Naked DNA gene transfer and therapy[ J]. Gene Ther, 2003, 10(6) : 453-458.
6Zhang G, Song YK, Liu D. Long-term expression of human alphal-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure[J]. Gene Ther, 2000, 7(15) : 1344-1349.
7Collins M, Ling V, Carreno BM, . The B7 family of ligands and its receptors : New pathways for costimulation and inhibition of immune responses[ J]. Annu Rev Immunol, 2002, 20: 29-53.
8Freeman G J, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [ J ]. J Exp Med, 2000, 192(7): 1027-1034.
9Hirano F, Kaneko K, Tamura H, et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity[J]. Cancer Res, 2005, 65(3) : 1089-1096.
10Latchman Y, Wood CR, Chemova T, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation [ J ]. Nat Immunol, 2001,2(3) : 261-268.
